Basic Cipramil Information

• INN (International Nonproprietary Name): Citalopram
• Brand Names Available In United Kingdom: Cipramil; generic citalopram (tablets 10 mg, 20 mg, 40 mg)
• ATC Code: N06AB04
• Forms & Dosages: Tablets oral 10 mg, 20 mg, 40 mg; oral solution 10 mg/mL in some regions
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription only (Rx)

Latest Research Highlights (Uk And Eu)

Are you wondering what recent studies say about cipramil and safety?

Meta-analyses and pooled randomised controlled trial data from 2022–2024 continued to place citalopram among established SSRIs for major depressive disorder, showing small-to-moderate benefit sizes versus placebo.

Comparative analyses indicate efficacy comparable to other SSRIs, with tolerability well described in the clinical literature.

Regulatory safety signals remain focused on dose-related QT prolongation and cardiac risk.

Real-world pharmacovigilance reinforced dose limits, with typical caps at 40 mg/day for most adults and 20 mg/day for older people, those with hepatic impairment or CYP2C19 poor metaboliser status.

UK prescribing audits reported stable citalopram use while sertraline and escitalopram prescriptions have risen, particularly among younger and anxiety-focused cohorts.

Generic preference remains strong across NHS formularies to reduce costs.

Patient-safety advice from regulators highlights ECG monitoring in high-risk patients and gradual tapering to reduce withdrawal symptoms.

Clinical Effectiveness In The Uk

Will cipramil help you in routine NHS care and how quickly?

NHS treatment data and patient-reported outcome measures show many people notice symptomatic improvement within 4–6 weeks of starting citalopram.

Typical NHS regimens start at 20 mg once daily and may be titrated to 40 mg if needed and tolerated.

Real-world outcomes match other SSRIs for remission but discontinuation rates can be higher for sexual dysfunction and early nausea.

Patients on NHS discussion boards commonly report benefit when GP follow-up occurs at 2–4 weeks.

Clinical audit advice recommends ECG review before escalating beyond 20 mg in older adults or in those with cardiac risk.

Response

Clinically meaningful reduction in depressive symptoms, typically judged at 4–6 weeks.

Remission

Minimal or no depressive symptoms sustained; goal of continued treatment.

Relapse

Return of depressive symptoms after improvement; addressed by maintenance therapy.

Indications And Expanded Uses

What is cipramil licensed for, and when is it used off‑label?

MHRA and European licences centre citalopram on major depressive disorder as the primary indication.

In NHS practice GPs and psychiatrists sometimes prescribe citalopram off‑label for anxiety spectrum disorders, panic disorder or neuropathic pain when alternatives are unsuitable.

Where a licensed alternative exists, prescribers generally choose that agent—for example sertraline or escitalopram for many anxiety presentations.

Off‑label prescribing should be recorded, justified and discussed with the patient with appropriate monitoring and informed consent.

• MHRA-Approved: Major Depressive Disorder
• Off-Label (Common, With Caveats): Generalised anxiety disorder, panic disorder, certain neuropathic pain referrals

Composition And Brand Landscape In The Uk

Which products labelled cipramil will you see in UK pharmacies?

The active ingredient is citalopram, often shown as citalopram hydrobromide on EU labelling.

Originator brand Cipramil (Lundbeck) and multiple generics are present across Europe and in UK supply chains, typically in 10 mg, 20 mg and 40 mg tablets.

Oral solution forms exist in some regions but tablets dominate UK dispensing.

ATC classification for citalopram is N06AB04 under selective serotonin reuptake inhibitors.

Community pharmacy chains and NHS dispensing generally favour generic citalopram for cost-effectiveness.

Contraindications And Special Precautions

Who should not take cipramil and who needs extra checks?

Absolute contraindications include concomitant MAO inhibitors (within 14 days), pimozide and known hypersensitivity to citalopram.

High‑risk groups include older adults, people with known long QT or family history of long QT syndrome, bradycardia, significant electrolyte disturbances and recent myocardial infarction or severe heart failure.

Pregnancy and breastfeeding require individual risk–benefit discussion and liaison with perinatal mental health teams and NICE guidance where available.

Advise caution with driving or operating machinery if drowsiness, dizziness or visual changes occur.

Alcohol should be limited because of additive CNS effects and worsening mood symptoms.

• Quick Checklist: MAOI use, pimozide, cardiac history, electrolytes, seizure history, pregnancy/breastfeeding status.

Dosage Guidelines

What doses are used on the NHS and who needs adjustments?

Standard adult initiation is 20 mg once daily for major depressive disorder, with response assessed at 2–4 weeks.

Typical maintenance dosing is 20–40 mg once daily, and the maximum recommended dose for most adults is 40 mg/day.

Special-population caps include elderly patients, those with hepatic impairment and CYP2C19 poor metabolisers, where 20 mg/day is usually the maximum.

Renal impairment usually does not require adjustment for mild to moderate disease, but severe renal impairment needs caution and closer monitoring.

Initial treatment duration is commonly a minimum 4–6 weeks for acute response, with 6–12 months continued after remission for a first episode.

Tapering should be gradual over weeks to months to reduce withdrawal symptoms such as dizziness or sensory disturbances.

Interactions Overview

Which medicines and substances should you avoid with cipramil?

Do not combine citalopram with MAO inhibitors due to the risk of serotonin syndrome, and avoid pimozide because of QT prolongation risk.

Citalopram interacts pharmacodynamically with other serotonergic drugs including SNRIs, triptans and tramadol which increases serotonin syndrome risk.

CYP2C19 inhibitors can raise citalopram levels and a dose reduction should be considered where clinically appropriate.

Concurrent use with antiplatelet agents or anticoagulants increases bleeding risk and co‑use with NSAIDs also raises that risk.

Alcohol potentiates central nervous system effects and should be limited during treatment.

• Major Interactions: MAO inhibitors, pimozide, other serotonergic agents, CYP2C19 inhibitors, antiplatelet/anticoagulant drugs, NSAIDs.

MHRA Yellow Card reports highlight rare but serious events such as QT prolongation, hyponatraemia (SIADH) and serotonin syndrome and clinicians and patients are encouraged to report suspected adverse drug reactions via the Yellow Card scheme.

Cultural Perceptions And Patient Habits

How do UK patients talk about cipramil and where do they seek help?

On UK forums such as Patient.info and similar discussion boards cipramil is often described as a reliable older SSRI with predictable side effects like nausea and sexual dysfunction.

Many patients expect pharmacist counselling and continuity with their GP when starting treatment, and they commonly use NHS online services and patient portals to manage repeats and report side effects.

Stigma remains a factor for some, but most value combined approaches such as medication plus talking therapies offered via IAPT.

Community pharmacists and high‑street chains provide practical advice and play a strong gatekeeper role for adherence and safety checks.

• Patient Behaviours: Consult GP first; seek pharmacist advice; use online NHS portals for repeats; share side‑effect experiences on forums.

IAPT

Improving Access to Psychological Therapies for mild-to-moderate depression and anxiety.

NHS 111

Non-emergency urgent care advice.

Samaritans

Emotional support for people in distress.

Availability And Pricing Patterns

How easy is it to get cipramil and what will it cost you in the UK?

Generic citalopram is widely available on NHS prescription across the United Kingdom and branded Cipramil is less commonly used in primary care due to cost.

Community pharmacy chains stock generics and can supply private prescriptions and repeat supplies, while online pharmacies offer e‑prescription services and home delivery.

Prescription charging differs by nation within the UK, with England charging per item unless exempt and Scotland, Wales and Northern Ireland having abolished prescription charges, which affects out‑of‑pocket cost and private demand.

NHS England bulk procurement keeps generic prices low and GPs generally prescribe by INN for cost-effectiveness.

In our online pharmacy, cipramil is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Prescribing Preferences

Which SSRIs are chosen instead of cipramil and why?

Common NHS alternatives include sertraline and escitalopram, often preferred for anxiety indications.

Fluoxetine is sometimes chosen because of its longer half‑life, and paroxetine is less favoured due to a higher risk of withdrawal symptoms.

Choice is guided by comorbidities, side‑effect profile, patient preference and local formulary and NICE guidance.

Citalopram remains an option within the SSRI class but clinicians apply ECG caution at higher doses and consider alternative SSRIs based on individual need.

Faq — Common NHS Patient Questions

How long will it take before I feel better?

Many patients notice some improvement after 2–4 weeks and meaningful change is often seen by 4–6 weeks.

Is 20 mg a full dose?

Twenty milligrams is a standard starting and maintenance dose, and adults may be prescribed up to 40 mg/day where appropriate and safe.

Will it affect my heart?

Most people have low cardiac risk, but dose-related QT prolongation is possible and older adults or patients with cardiac risk may need ECG monitoring and a 20 mg/day cap.

How do I stop it?

Do not stop abruptly; taper gradually under GP supervision to reduce withdrawal such as dizziness or sensory changes.

For urgent concerns contact NHS 111 or your GP and report suspected adverse reactions to the MHRA Yellow Card scheme.

Guidelines For Proper Use

What should a pharmacist cover when counselling a patient starting cipramil?

Confirm the indication and review all current medicines including over‑the‑counter and herbal products.

Ask about allergies, cardiac history, electrolyte problems and current pregnancy or breastfeeding plans.

Explain common side effects such as nausea, sleep disturbance and sexual dysfunction, and advise on what to do if severe symptoms occur.

Discuss the importance of follow-up at 2–4 weeks and when to seek help for signs of serotonin syndrome, severe hyponatraemia or mood worsening.

• Counselling Checklist: Indication, concomitant meds, MAOI risk, cardiac history, monitoring schedule, how to taper and where to report side effects.

NHS Patient Portal

For repeat prescription requests and secure messaging with GP practices.

Yellow Card App

For reporting suspected adverse drug reactions to the MHRA.

Local Mental Health Team

Referral routes and perinatal psychiatry where required.

Pharmacies commonly use electronic prescriptions and repeat dispensing, and patients should be advised how to request repeats through their GP practice or pharmacy repeat dispensing schemes.

Delivery Across United Kingdom